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Co-infections with Respiratory Viruses in Dogs with Bacterial
Pneumonia
S.J. Viitanen, A. Lappalainen, and M.M. Rajam€aki
Background: Bacterial pneumonia (BP) is an inﬂammation of the lower airways and lung parenchyma secondary to bacte-
rial infection. The pathogenesis of BP in dogs is complex and the role of canine respiratory viruses has not been fully evaluated.
Objectives: The aim of this study was to investigate the occurrence of viral co-infections in dogs with BP and to assess
demographic or clinical variables as well as disease severity associated with viral co-infections.
Animals: Twenty household dogs with BP caused by opportunistic bacteria and 13 dogs with chronic (>30 days) tracheo-
bronchitis caused by Bordetella bronchiseptica (BBTB).
Methods: Prospective cross-sectional observational study. Diagnosis was conﬁrmed by clinical and laboratory ﬁndings,
diagnostic imaging, and cytologic and microbiologic analysis of bronchoalveolar lavage or transtracheal wash ﬂuid. Canine
parainﬂuenza virus (CPIV), canine adenovirus, canine herpes virus, canine inﬂuenzavirus, canine distemper virus, canine
respiratory coronavirus (CRCoV) and canine pneumovirus, as well as B. bronchiseptica and Mycoplasma spp. were analyzed
in respiratory samples using PCR assays.
Results: CPIV was detected in 7/20 and CRCoV in 1/20 dogs with BP. Respiratory viruses were not detected in dogs with
BBTB. There were no signiﬁcant diﬀerences in clinical variables between BP dogs with and without a viral co-infection.
Conclusion and Clinical Importance: Respiratory viruses were found frequently in dogs with BP and may therefore play
an important role in the etiology and pathogenesis of BP. Clinical variables and disease severity did not diﬀer between BP
dogs with and without viral co-infection.
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Bacterial pneumonia (BP) is an acquired inﬂammationof the lower airways and lung parenchyma secondary
to bacterial infection.1 Because BP is diﬃcult to induce
experimentally in healthy animals, the pathogenesis is
considered complex and involves several underlying
mechanisms.2 Possible predisposing factors for the devel-
opment of BP, such as diseases leading to aspiration,
decreased ciliary function, or immunodeﬁciency, have
been described in Dogs.3 However, the role of canine
respiratory viruses in the development of BP and the pos-
sible connection between canine infectious respiratory
disease (CIRD) and BP have not yet been fully evaluated.
Canine infectious respiratory disease, also known as
infectious tracheobronchitis or kennel cough, is consid-
ered 1 of the most common infectious diseases in dogs
worldwide.4 It is highly contagious and aﬀects the larynx,
trachea, bronchi, and nasal mucosa, causing acute
respiratory signs, mainly cough, which usually are self-
limiting.4 Because of the contagious nature of CIRD, it is
most prevalent in dense dog populations such as in
kennels and rehoming centers.4 Canine infectious respira-
tory disease has a multifactorial etiology, and several
respiratory viruses as well as bacterial pathogens have
been shown to contribute to the disease complex.4–6
Canine parainﬂuenza virus (CPIV) and canine adenovirus
type 2 (CAV-2) were ﬁrst detected in dogs with conta-
gious tracheobronchitis in the 1960s, and since then these
viruses have been considered as the principal etiologic
agents in CIRD.7–10 Canine herpes virus (CHV) also was
detected in dogs with respiratory signs decades ago, but
its role in CIRD remains controversial.11–14 In addition to
these pathogens, novel respiratory viruses recently have
been reported. Canine respiratory coronavirus (CRCoV)
was ﬁrst identiﬁed in 2003 in dogs at a rehoming center in
the United Kingdom.15 Subsequently, evidence of conta-
gious tracheobronchitis caused by CRCoV has been
reported worldwide.16–20 Canine inﬂuenza virus (CIV)
was ﬁrst described in a racing Greyhound population in
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BALF bronchoalveolar lavage ﬂuid
BBTB tracheobronchitis caused by Bordetella bronchiseptica
BP bacterial pneumonia
CAP community-acquired pneumonia
CAV-2 canine adenovirus type 2
CDV canine distemper virus
CIRD canine infectious respiratory disease
CIV canine inﬂuenza virus
CHV canine herpes virus
CnPnV canine Pneumovirus
CPIV canine parainﬂuenza virus
CRCoV canine respiratory coronavirus
CRP C-reactive protein
TTW transtracheal wash
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the United States in 2004, and it was later shown that
CIV is widespread in the USA.21–23 Canine pneumovirus
(CnPnV) recently was discovered in dogs with respiratory
disease in the United States, but the role of CnPnV as a
causative agent in CIRD still is not fully known.24–26 In
addition to viral agents, some bacterial pathogens such as
Bordetella bronchiseptica, Mycoplasma spp., and more
recently Streptococcus equi sp. zooepidemicus, have been
shown to contribute to the etiology of CIRD.27–32
Although not considered part of the CIRD complex,
canine distemper virus (CDV) is an important respiratory
pathogen causing severe systemic disease characterized by
a variety of clinical signs, including respiratory signs.33
Viral-bacterial co-infections in the respiratory tract are
well documented in humans with community-acquired
pneumonia (CAP), and epidemiologic data as well as
laboratory studies support the conclusion that respira-
tory viruses predispose to the development of secondary
bacterial infections.34,35 Several mechanisms have been
shown to contribute to this situation: Viruses destroy the
respiratory epithelium and facilitate bacterial adhesion,
viral infection up-regulates expression of molecules that
bacteria utilize as receptors, and virus-induced immuno-
suppression promotes secondary bacterial infection.35,36
Recent advances in molecular diagnostic techniques have
greatly increased understanding of the etiology of CAP
in humans. Viruses aﬀecting the lower respiratory tract
currently are recognized as causative and complicating
factors in up to 40% of humans with CAP.37–39
Preceding or concurrent infections with CIRD viruses
also have been considered as a possible etiological fac-
tor in dogs with BP, although there currently are only
isolated reports suggesting this connection.1,40,41 In
dogs, BP most often is caused by opportunistic bacteria
that belong to the normal oral ﬂora.42,43 However, pub-
lished studies on viral-bacterial co-infections in dogs
almost exclusively describe dogs housed in dense popu-
lations, such as kennels or rehoming centers, that are
infected with respiratory viruses and bacteria belonging
to the CIRD complex.6,7,44 Nevertheless, it is likely that
respiratory viruses also are an important etiologic factor
in dogs with BP caused by opportunistic bacteria in a
similar manner as has been reported in humans.
The purpose of this study was to investigate the
occurrence of viral respiratory infections in household
dogs diagnosed with BP and to assess the possible
demographic or clinical variables associated with viral
co-infections as well as to assess the impact of viral co-
infections in the severity of the disease.
Materials and Methods
Study Design
The study was conducted as a prospective cross-sectional obser-
vational study. A prior sample size calculation was not performed.
Study Population
Privately owned household dogs diagnosed with BP at the Vet-
erinary Teaching Hospital of the University of Helsinki between
March 2011 and October 2013 were eligible for inclusion in the
study. Dogs with prolonged (duration of clinical signs >30 days)
tracheobronchitis caused by Bordetella bronchiseptica (BBTB) were
included as controls for the virus analysis.
All dogs living in or being recently (<4 weeks ago) exposed to
environments with high infection pressure (eg, boarding kennels,
rescue shelters) were excluded. Dogs that had been vaccinated
against CDV, CAV-2, CPIV, or B. bronchiseptica <4 weeks before
inclusion in the study were excluded.
Diagnostic Testing and Sample Collection
A full clinical examination was performed, with special empha-
sis on the respiratory tract. Thoracic radiographs (laterolateral
and ventrodorsal or dorsoventral views) were obtained at presenta-
tion and assessed by the same radiologist (AL), who was blinded
to the patient data. Hematology, serum biochemistry, serum C-
reactive protein (CRP) and fecal analysis were performed. Arterial
blood gas analysis for partial pressures of oxygen and carbon
dioxide were measured and the alveolar-arterial gradient was cal-
culated. Bronchoscopy was performed with a 4.9-mm ﬂexible
endoscope,a and airway samples for cytology, semiquantitative aer-
obic and anaerobic bacterial culture, qualitative Mycoplasma spp.
culture and PCR analysis were obtained by weight-adjusted (1 ml/
kg 0.9% NaCl) bronchoalveolar lavage (BAL).45 Transtracheal
wash (TTW) sampling was used in dogs with BP in which anesthe-
sia was considered unsafe because of the severity of the disease.46
Bacterial pneumonia was diagnosed when there were typical
acute signs (at least 3 of the following: fever, lethargy, dyspnea,
tachypnea, cough) and ﬁndings compatible with BP on thoracic
radiographs.1,42,43 A bacterial origin was proved by cytological
conﬁrmation of bacterial infection in respiratory samples (>2 intra-
cellular bacteria/oil immersion ﬁeld), positive bacterial culture
(≥103 colony-forming units/mL in airway samples),47 or rapid
response to antibiotics and full clinical and radiographic normaliza-
tion with antibiotic treatment. All dogs with BP were followed until
full cure. Prolonged BBTB was diagnosed when there was a cough
lasting for >30 days and a positive bacterial culture of B. bronchi-
septica (>103 colony-forming units/mL) in bronchoalveolar lavage
ﬂuid (BALF) and an absence of other diagnosed airway pathology.
Sample Handling and Analysis
Hematology, serum biochemistry, arterial blood gas analysis,
serum CRP, and fecal analysis as well as cytologic and microbio-
logic analysis of respiratory samples were performed as previously
described.48 Semiquantitative bacterial culture of BALF and TTW
ﬂuid was performed as follows: A 10-lL volume of the specimen
was streaked onto agars. Bacterial counts were quantiﬁed by cal-
culating the colonies on a plate and multiplying the number of col-
onies by the dilution factor. The limit of detection was
100 colony-forming units/mL. The remaining respiratory samples
(BALF, TTW) and serum were immediately frozen and stored at
80°C. CPIV, CAV-2, CHV, CIV, CDV, and CRCoV, as well as
Mycoplasma spp. and B. bronchiseptica, were analyzed by real-time
PCR analysis at a commercial reference laboratory.b 6 CnPnV was
analyzed by RT-PCR at the laboratoryc responsible for the discov-
ery of this pathogen.25
Statistical Analysis
Normality testing was based on Shapiro–Wilk’s test of normal-
ity and normal Q–Q plots. The diﬀerences between groups with
negative and positive virus PCR were evaluated using the indepen-
dent samples Student’s t-test (normally distributed variables) and
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Mann–Whitney U-test (non-normally distributed variables). The
Mann–Whitney U-test also was used to evaluate whether there
were diﬀerences in BALF and TTW diﬀerential cell counts in all
dogs with BP. P-values < .05 were considered statistically signiﬁ-
cant. All statistical analyses were performed using commercial sta-
tistical software.d
Ethical Approval and Owner Consent
This study was approved by the Ethics Committee of the Uni-
versity of Helsinki. Owner consent was obtained from the owners
of the dogs before participation.
Results
Dogs
Altogether, 33 dogs were included in the study, con-
sisting of 20 dogs diagnosed with BP (10/20 male and
10/20 female) and 13 with BBTB (8/13 male and 5/13
female). The age distribution and weights of dogs with
BP are presented in Table 1. Dogs in both groups rep-
resented various breeds without over-representation of
any single breed.
Other simultaneous respiratory diseases or bacterial
infections were identiﬁed in 4/12 dogs (chronic bronchi-
tis 2/4, tracheoesophageal ﬁstula 1/4, oral abscess 1/4).
Laryngeal examination was not performed in dogs with
BP and therefore aspiration etiology could not be fully
excluded. All dogs with BP presented as acute (median
duration of clinical signs, 1 day; range, 0.5–7 days; in-
terquartile range, 1–3.8 days) emergency cases of vary-
ing severity (14/20 dogs required hospitalization for a
median duration of 1.8 days; interquartile range, 1–
4.6 days), and none of the dogs died or was euthanized.
All dogs with BBTB were clinically stable and were
presented with chronic cough (median duration of clini-
cal signs, 120 days; interquartile range, 60–186 days).
Clinical Findings
Body temperature, respiratory rate, serum CRP,
results from arterial blood gas analysis and hematology,
as well as information on the duration of clinical signs
and duration of hospitalization in dogs with BP are pre-
sented in Table 1. Fecal analysis results were available
for 15/20 dogs with BP, and they were all negative for
lung worms and intestinal parasites. Radiographic ﬁnd-
ings in dogs with BP are presented in Table 2. Demo-
graphic and clinical data in dogs with and without viral
co- infection were compared and results are presented
in Tables 1 and 3. Dogs with viral co-infections were
signiﬁcantly heavier (P = .037) than dogs with negative
virus PCR results. Duration of clinical signs or hospital-
ization, age of the dogs, body temperature, respiratory
rate, serum CRP, hematology, arterial blood gas analy-
sis, and BALF and TTW cytology results did not diﬀer
signiﬁcantly between dogs with and without viral co-
infection.
Respiratory Samples
In the PCR analysis of BALF or TTW ﬂuid, CPIV
was detected in 7/20 (35%; 95% conﬁdence interval,
14–56%) and CRCoV in 1/20 (5%; 95% conﬁdence
interval, 0–15%) dogs with BP. CAV-2, CHV, CIV,
CDV, or CnPnV were not detected in any of the sam-
ples. Dogs with positive virus PCR did not have other
diseases predisposing to BP. Respiratory viruses were
not detected in dogs with BBTB.
Table 1. Comparison of demographic and clinical ﬁndings in dogs with bacterial pneumonia with positive and nega-
tive respiratory virus PCR results.
Negative Respiratory
Virus PCR (n = 12)
Positive Respiratory
Virus PCR (n = 8) P-Value
Sex Male 5/12 Male 5/8
Female 7/12 Female 3/8
Mean  SD Mean  SD
Weight (kg) 25.0  16.4 41.7  15.7 .037
Body temperature (C) 39.6  0.9 39.2  0.8 .31
Respiratory rate (breaths/min) 59  21 45  20 .15
Arterial paO2 (mmHg) 74.9  11.1 79.1  14.1 .49
Arterial paCO2 (mmHg) 29.3  3.9 30.9  1.1 .19
Alveolar-arterial O2 gradient 41.3  11.8 33.5  14.4 .23
Median (IQR) Median (IQR)
Age, years 5.8 (1.3–8.4) 0.9 (0.7–1.4) .057
Duration of clinical signs (days) 1.0 (1–3.5) 3.0 (1.0–5.3) .48
Duration of hospitalization (days) 1.8 (0.0–4.8) 1.0 (0.3–1.5) .43
Serum C-reactive protein (mg/L) 140 (84–192) 63 (52–178) .98
Blood leukocyte count (109/L) 14.6 (12.5–22.0) 10.6 (7.4–22.9) .34
Segmented neutrophil count (109/L) 11.7 (9.1–15.6) 7.8 (5.2–17.5) .27
Band neutrophil count (109/L) 0.5 (0.08–2.0) 0.3 (0.0–0.9) .48
Lymphocyte count (109/L) 0.7 (0.4–1.7) 1.5 (0.4–3.6) .52
Eosinophil count (109/L) 0.3 (0.0–0.6) 0.2 (0.0–0.6) .91
Monocyte count (109/L) 1.0 (0.3–1.7) 0.7 (0.5–1.5) .97
Basophil count (109/L) 0.0 (0.0–0.0) 0.0 (0.0–0.0) .68
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Respiratory samples were retrieved using BAL in 13/
20 and TTW in 7/20 dogs diagnosed with BP. BAL was
used as a sampling method in all dogs with BBTB.
Results from cytology analysis of BALF and TTW ﬂuid
in BP dogs are presented in Table 3. Because BALF
and TTW ﬂuid cytology did not diﬀer signiﬁcantly in
other variables aside from the percentage of epithelial
cells (median in BALF, 0.0; interquartile range, 0.0–0.0
versus median in TTW ﬂuid, 0.7; interquartile range,
0.0–14.7; P = .008), combined results are represented
for the 2 sampling techniques.
Altogether, 11/20 dogs with BP had received antimi-
crobials before sampling. Signiﬁcant bacterial growth
(≥103 colony-forming units/mL in BALF or TTW ﬂuid)
was identiﬁed in the primary culture in 11/20 samples
(5/11 dogs with prior antimicrobial treatment). A single
species was isolated in 8/11 samples, including Pasteurella
sp. (1/10), Escherichia coli (2/10), Streptococcus sp.
(2/10), Hemophilus sp. (1/10), Mycoplasma sp. (1/10),
and Nocardiopsis sp. (1/10), and 2 species in 3 samples,
Pasteurella sp. and Mycoplasma sp.47 Intracellular bac-
teria were seen in 6/11 dogs with signiﬁcant bacterial
growth in primary culture. In 1 dog with a negative pri-
mary culture and prior antimicrobial treatment, >2
intracellular bacteria/oil immersion ﬁeld were demon-
strated, and Actinomyces sp. was cultured after enrich-
ment.47 Positive bacterial growth was detected only
after enrichment in 4/20 dogs (single species of bacteria,
including Streptococcus sp. [1/4], Pasteurella sp. [1/4]),
Haemophilus sp. [1/4], and Actinomyces sp. [1/4]), 2 of
these dogs had received prior antimicrobial treatment.
A negative bacterial culture in airway samples was
recorded in 4/20 dogs (2 had received prior antimicro-
bial treatment), but they showed an acute onset of
respiratory signs and had new alveolar densities in tho-
racic radiographs as well as neutrophilia in BALF
cytology. All of these dogs showed a rapid response to
antibiotics, and a full clinical and radiographic cure was
Table 2. Radiographic ﬁndings in dogs with bacterial pneumonia with positive and negative respiratory virus PCR
results.
Radiographic Pattern Number of Dogs
Location
Number of Dogs
Negative virus PCR (n = 12) Alveolar, single lobe 4/12 Right cranial lobe 1/4
Right caudal lobe 1/4
Left cranial cranial lobe 1/4
Left caudal cranial lobe 1/4
Alveolar, multiple lobes 5/12 Right cranial lobe 3/5
Right middle lobe 1/5
Right caudal lobe 1/5
Left cranial cranial lobe 3/5
Left caudal cranial lobe 1/5





Positive virus PCR (n = 8) Alveolar, single lobe 2/8 Right middle lobe 2/2
Alveolar, multiple lobes 4/8 Right cranial lobe 2/4
Right middle lobe 3/4
Left cranial cranial lobe 2/4





Table 3. Comparison of cytological analysis of bronchoalveolar lavage and transtracheal wash ﬂuid in dogs with
bacterial pneumonia with positive and negative respiratory virus PCR results.
Negative Respiratory Virus PCR (n = 12) Positive Respiratory Virus PCR (n = 8)
P-ValueMedian (IQR) Median (IQR)
Total cell count (109/L) 1.4 (0.1–10.6) 4.7 (0.2–31.7) .57
Neutrophils (%) 66.1 (7.7–95.9) 65.2 (12.0–90.2) .91
Eosinophils (%) 0.4 (0.0–9.0) 1.0 (0.1–3.5) .62
Mast cells (%) 0.0 (0.0–1.8) 0.0 (0.0–0.0) .57
Lymphocytes (%) 5.0 (0.7–16.6) 4.7 (0.4–20.4) 1.00
Macrophages (%) 23.7 (3.7–57.9) 22.1 (8.2–57.6) 1.00
Epithelial cells (%) 0.0 (0.0–0.0) 0.0 (0.0–0.7) .57
Basophils (%) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.00
Plasma cells (%) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.00
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achieved with antimicrobial treatment. CPIV was
detected by PCR in 2/4 and Mycoplasma spp. in 1/4
dogs with negative culture results.
Information on previous CDV, CAV-2, and CPIV
vaccinations was available for all dogs with BP. All
dogs with positive CPIV PCR in respiratory samples
(n = 7) had been vaccinated against CPIV <12 months
previously (median, 6.5 months; interquartile range,
4.5–9.0 months). In total, 12/13 dogs with negative
CPIV PCR in respiratory samples were vaccinated
against CPIV (median, 13.0 months; interquartile range
2.9–24 months). There was no signiﬁcant diﬀerence in
the timing of CPIV vaccination between dogs with posi-
tive and negative respiratory virus PCR (P = .152). All
dogs participating in this study had previously been
vaccinated against CAV and CDV.
Bordetella bronchiseptica PCR analysis was positive in
12/13 dogs with BBTB and 1/20 dogs with BP. All dogs
with BBTB and none of the dogs with BP had positive
growth of B. bronchiseptica in BALF or TTW ﬂuid.
In addition to Mycoplasma spp. PCR analysis, a cul-
ture for Mycoplasma spp. was performed in 15/20 dogs
with BP and 4/13 dogs with BBTB. Mycoplasma PCR
was positive in 8/20 dogs with BP and 3/13 dogs with
BBTB. Mycoplasma culture was positive in 4/15 dogs
with BP and 2/4 dogs with BBTB. Mycoplasma PCR
was positive in all dogs with BP and BBTB with posi-
tive culture results. Additionally, PCR was positive in 3
dogs with negative Mycoplasma culture results (2 dogs
with BP and 1 with BBTB) and in 2 dogs with BP lack-
ing culture results.
Discussion
Bacterial pneumonia is a serious lower respiratory
tract infection in dogs with substantial morbidity and
risk of mortality. Although BP was described in Dogs
decades ago, information on the mechanisms leading to
the development of the disease still is limited. Factors
such as diseases predisposing to aspiration, immunodeﬁ-
ciency, or ciliary dysfunction that lead to impairment of
pulmonary defense mechanisms and thereby predispose
to the development of BP have been described.3 How-
ever, the role of preceding or concurrent infections with
CIRD viruses has not been fully evaluated in dogs with
BP, although it has been suspected to play a role in the
etiology, as reported in humans with CAP.34–39 Previ-
ously, respiratory viral-bacterial co-infections mostly
have been reported in dogs housed in dense popula-
tions, such as kennels and rescue shelters, and bacteria
accompanying viruses have been primary CIRD bacte-
ria (B. bronchiseptica, S. equi sp. zooepidemicus, and
Mycoplasma spp.).6,7,19,44
Our study indicates that respiratory viruses, primarily
CPIV, frequently are also found in dogs with BP, which
is caused by opportunistic bacteria. Therefore, it is
likely that CIRD viruses can predispose dogs to oppor-
tunistic bacterial lung infections by increasing bacterial
adhesion, as has been reported in humans.35
In this study, CPIV was the most common viral path-
ogen detected, which is in accordance with previous
reports describing viruses responsible for CIRD in dif-
ferent countries.6,13,19 Novel CRCoV was detected in 1
dog with BP, further demonstrating that CRCoV has a
worldwide distribution and also may be detected in
Northern Europe.
Canine parainﬂuenza virus was prevalent despite
recent vaccination, which can be considered indicative
of poor vaccine-induced antibody coverage against
CPIV. In contrast, CAV and CDV were not encoun-
tered in dogs vaccinated against these viruses. This ﬁnd-
ing is in accordance with previous reports. In a
longitudinal study on respiratory viruses in a rehoming
center in England, CPIV was commonly detected
despite regular vaccinations, but CDV and CAV-2 were
not encountered, most likely because of adequate vacci-
nation coverage.13 It remains unknown whether more
eﬃcient CPIV vaccines and possible CRCoV vaccina-
tions could decrease the incidence of BP, as has been
shown in humans, in whom protection against inﬂuenza
and respiratory syncytial virus decreased the incidence
of secondary bacterial infections.50–52
Nosocomial infections with respiratory viruses also
have been reported in dogs. An outbreak of CPIV was
described in an animal hospital and an outbreak of
CHV was reported in immunocompromised dogs.53,54
Because co-infections with CIRD viruses are shown to
be common in dogs with BP, the infection risk needs to
be taken into account when treating BP patients in the
same premises (eg, intensive care units) with immuno-
compromised patients.
Dogs with viral co-infections were signiﬁcantly hea-
vier than those without virus infection. This ﬁnding
might be inﬂuenced by the structure of the virus-nega-
tive group: All 4 dogs with another predisposing factor
for the development of BP were <20 kg (West Highland
White Terrier, Dachshund, Spanish Water Dog, and
Schnauzer). Dogs with viral co-infections also were
younger than those without viral co-infection, although
this did not reach statistical signiﬁcance. This ﬁnding is
not unexpected, because young animals might have
insuﬃcient acquired immunity against CIRD viruses.2
Clinical ﬁndings, arterial blood gas analysis, and
hematology, as well as respiratory sample cytology in
both groups were in accordance with previously
reported ﬁndings in BP and did not diﬀer between
virus-negative and virus-positive groups.42,43,48 On tho-
racic radiographs, an alveolar pattern in the cranial and
the middle lobes was predominant in both groups with-
out group predisposition. Radiographic ﬁndings in dogs
with BP have been thoroughly reported previously for
cases of aspiration etiology.55,56 In our study, radio-
graphic ﬁndings in dogs with BP caused by other etiolo-
gies were similar to those reported for aspiration
pneumonia. Aspiration etiology was considered unli-
kely, because none of the dogs with BP had a history of
vomiting, regurgitation, recent anesthesia or signs com-
patible with laryngeal paralysis. Our ﬁndings could indi-
cate that an alveolar pattern in cranial and middle lung
lobes may be typical for pneumonia, regardless of etiol-
ogy. On the other hand, aspiration pneumonia might
have played a role in some dogs but could not be
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conﬁrmed or denied based on available history, exami-
nation ﬁndings, or imaging. We were unable to identify
clinical variables to reliably distinguish dogs with BP
and viral co-infection, and PCR testing therefore
appears to be required to identify viral respiratory
infections in dogs with BP. A similar ﬁnding was
reported in humans.57
There were no signiﬁcant diﬀerences in the duration
of hospitalization (P = .427) or partial pressures of arte-
rial oxygen at presentation (P = .343) between BP dogs
with and without viral co-infection, indicating that viral
co-infections do not appear to cause a more severe
course of BP. In dogs, limited information is available
on the severity of BP of diﬀerent etiological origins,
and in humans the reports are contradictory. Some
studies have shown that mixed infections with viruses
and bacteria induce a more severe clinical disease,
whereas others have been unable to demonstrate signiﬁ-
cant diﬀerences in disease severity.49,58–61
Previous studies reporting microbiological ﬁndings in
dogs with pneumonia have found growth of a single spe-
cies of bacteria in 40–74% of cases.42,43 All of these stud-
ies used TTW as a sampling method. Factors that might
have inﬂuenced the ﬁnding of primarily a single species
of bacteria in our study may be the use of BAL as a sam-
pling method in majority of cases, compared to previous
studies where TTW was used and the widespread use of
prior antimicrobial treatments in these dogs.
Novel molecular methods have allowed the rapid test-
ing of several respiratory pathogens simultaneously.
Lower respiratory tract samples are considered ideal
when diagnosing viral respiratory infections in humans
with CAP, and it has been shown that virus-positive
PCR in BALF is associated with respiratory symptoms
in humans.62,63 Naturally, the invasiveness of retrieving
BALF, compared to upper respiratory sampling, limits
the usefulness of this accurate sample. However, espe-
cially when using molecular methods, virus recovery
from the upper respiratory tract may be suggestive of
virus exposure rather than indicative of an active viral
infection.6 We chose lower respiratory tract samples in
order to decrease the number of false-positive results,
but a comparison of PCR ﬁndings between upper and
lower respiratory tract samples would be useful. Under-
estimation of virus-positive PCR results may have
occurred in our dogs in cases in which viral infection
preceded BP and sampling was performed outside of
the viral shedding period.
Bordetella bronchiseptica and Mycoplasma spp. were
tested using both PCR and conventional culture meth-
ods. Polymerase chain reaction was, as expected, able
to reliably demonstrate both pathogens in dogs with
positive culture results. Additionally, Mycoplasma PCR
was positive in 3 dogs with negative culture results. The
clinical relevance of these positive results is diﬃcult to
interpret, because Mycoplasma spp. are also encoun-
tered in the respiratory tract of healthy dogs.64 On the
other hand, because Mycoplasma requires special cul-
ture methods (and in this study also shipping to an out-
side laboratory), there might have been dogs in which
Mycoplasma culture was falsely negative. Quantitative
PCR might have aided in assessing the clinical relevance
of these PCR ﬁndings.
Respiratory viruses were not detected in control dogs
with prolonged BBTB. Bordetella bronchiseptica com-
monly accompanies CIRD viruses in acute respiratory
infections and signs usually are self-limiting.6,19,28,29
Dogs with prolonged BBTB were considered more
likely than those of the general dog population to have
been exposed to CIRD viruses previously. Infections
with CIRD viruses are self-limiting within the ﬁrst
weeks, and because all BBTB dogs had prolonged clini-
cal signs, an active viral infection therefore was consid-
ered unlikely.7,9,11,65 Consequently, the negative results
in the BBTB group are considered to increase the reli-
ability of positive virus PCR ﬁndings in dogs with BP.
The most important limitation in this study was the
small number of dogs in each group. This decreases sta-
tistical power (ie, the possibility of detecting a true dif-
ference between groups or reporting a diﬀerence that
does not truly exist). Additionally, because this study
was performed in Northern Europe in household dogs
with low infection pressure, the results may not be
applicable in all situations.
In conclusion, respiratory viruses, primarily CPIV,
were found frequently in lower respiratory samples of
dogs with BP and may play an important role in the
etiology and pathogenesis of BP. Additionally, clinical
variables and disease severity did not diﬀer between BP
dogs with and without viral co-infection.
Footnotes
a Olympus GIF N180, Olympus Medical Systems Europa GMBH,
Hamburg, Germany
b IDEXX GmbH, M€orikestraße 28/3, D-71636 Ludwigsburg, Ger-
many
c Animal Health Diagnostic Centre, College of Veterinary Medi-
cine, Cornell University, 240 Farrier Road, Ithaca, NY 14853
d PASW Statistics 18, SPSS Inc, 233 South Wacker Drive, Chi-
cago, IL
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